The Role of Glucose Metabolism in Alzheimer’s Disease

Alzheimer’s disease (AD) is a progressive neurological disorder characterized by the accumulation of misfolded beta-amyloid and tau proteins in the brain. This accumulation leads to the deterioration of neuronal connections, resulting in cognitive decline and...

Evolution of Medicine: From 1.0 to 3.0

The evolution of medicine over the centuries has been marked by significant milestones that have transformed healthcare practices and outcomes. This article explores the journey from Medicine 1.0, through Medicine 2.0, to the emerging paradigm of Medicine 3.0. Each...

Gene Variant Slows Form of Inherited Alzheimer’s Disease

Variations in certain genes can modify the risk of developing Alzheimer’s disease (AD) and other types of dementia. Some of the best-understood variants to date are in a gene called APOE. This gene plays a role in the transport of cholesterol and other fatty molecules...

Comprehensive Metabolic Health Assessment: Beyond HbA1c

The silent progression of type II diabetes (T2D) poses a significant challenge in modern healthcare. Often asymptomatic in its early stages, T2D can wreak havoc on the body for years before clinical symptoms manifest. This underscores the critical importance of early...

Evaluating Carcinogenic Risks for Firefighters

A Brief History of the IARC Monographs Program The International Agency for Research on Cancer (IARC) was established in 1965 to address growing concerns about carcinogenic risks. In 1970, an advisory committee recommended creating a compendium on carcinogenic...

First 5T MRI to Offer Whole-Body Imaging Scores FDA Clearance

On May 2, 2024, a groundbreaking advancement in medical imaging was achieved as the U.S. Food and Drug Administration (FDA) granted clearance for the first 5T MRI scanner designed for whole-body applications. This milestone was announced by United Imaging, a Houston,...